These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30389404)

  • 1. Epithelial-mesenchymal transition: Initiation by cues from chronic inflammatory tumor microenvironment and termination by anti-inflammatory compounds and specialized pro-resolving lipids.
    Lee CH
    Biochem Pharmacol; 2018 Dec; 158():261-273. PubMed ID: 30389404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of Epithelial-Mesenchymal Transition by Natural Anti-Inflammatory and Pro-Resolving Lipids.
    Lee CH
    Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31766574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic implications of cancer epithelial-mesenchymal transition (EMT).
    Cho ES; Kang HE; Kim NH; Yook JI
    Arch Pharm Res; 2019 Jan; 42(1):14-24. PubMed ID: 30649699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
    Du B; Shim JS
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secreted molecules inducing epithelial-to-mesenchymal transition in cancer development.
    Dalla Pozza E; Forciniti S; Palmieri M; Dando I
    Semin Cell Dev Biol; 2018 Jun; 78():62-72. PubMed ID: 28673679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial-mesenchymal transition and inflammation at the site of the primary tumor.
    Dominguez C; David JM; Palena C
    Semin Cancer Biol; 2017 Dec; 47():177-184. PubMed ID: 28823497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Icariside II inhibits the EMT of NSCLC cells in inflammatory microenvironment via down-regulation of Akt/NF-κB signaling pathway.
    Song J; Feng L; Zhong R; Xia Z; Zhang L; Cui L; Yan H; Jia X; Zhang Z
    Mol Carcinog; 2017 Jan; 56(1):36-48. PubMed ID: 26859114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
    Su L; Luo Y; Yang Z; Yang J; Yao C; Cheng F; Shan J; Chen J; Li F; Liu L; Liu C; Xu Y; Jiang L; Guo D; Prieto J; Ávila MA; Shen J; Qian C
    Cancer Res; 2016 Sep; 76(17):5054-67. PubMed ID: 27364559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation.
    Fuxe J; Karlsson MC
    Semin Cancer Biol; 2012 Oct; 22(5-6):455-61. PubMed ID: 22627188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer Metastasis.
    Lee GA; Hwang KA; Choi KC
    Toxins (Basel); 2016 May; 8(6):. PubMed ID: 27231938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis.
    Li H; Xu F; Li S; Zhong A; Meng X; Lai M
    Cell Adh Migr; 2016 Jul; 10(4):434-46. PubMed ID: 26743180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review.
    Wang S; Huang S; Sun YL
    Biomed Res Int; 2017; 2017():2646148. PubMed ID: 29379795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant cancer metabolism in epithelial-mesenchymal transition and cancer metastasis: Mechanisms in cancer progression.
    Huang R; Zong X
    Crit Rev Oncol Hematol; 2017 Jul; 115():13-22. PubMed ID: 28602165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory effects of docosahexaenoic acid: Implications for its cancer chemopreventive potential.
    Yum HW; Na HK; Surh YJ
    Semin Cancer Biol; 2016 Oct; 40-41():141-159. PubMed ID: 27546289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
    Drak Alsibai K; Meseure D
    Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory fibroblasts in cancer.
    Lim H; Moon A
    Arch Pharm Res; 2016 Aug; 39(8):1021-31. PubMed ID: 27384063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
    Kim YJ; Jeon Y; Kim T; Lim WC; Ham J; Park YN; Kim TJ; Ko H
    Bioorg Med Chem Lett; 2017 Feb; 27(4):1081-1088. PubMed ID: 28110870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal Stem Cells, Immune Cells and Tumor Cells Crosstalk: A Sinister Triangle in the Tumor Microenvironment.
    Razmkhah M; Abtahi S; Ghaderi A
    Curr Stem Cell Res Ther; 2019; 14(1):43-51. PubMed ID: 30112998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells.
    Navas T; Pfister TD; Colantonio S; Aziz A; Dieckman L; Saul RG; Kaczmarczyk J; Borgel S; Alcoser SY; Hollingshead MG; Lee YH; Bottaro DP; Hiltke T; Whiteley G; Takebe N; Kinders RJ; Parchment RE; Tomaszewski JE; Doroshow JH
    PLoS One; 2018; 13(6):e0199361. PubMed ID: 29928062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative proteomic analysis reveals reprograming tumor necrosis factor signaling in epithelial mesenchymal transition.
    Zhao Y; Tian B; Sadygov RG; Zhang Y; Brasier AR
    J Proteomics; 2016 Oct; 148():126-38. PubMed ID: 27461979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.